Metric: Use of ADHD drugs among adults soars

Medco Health Solutions reports that the number of young adults taking attention deficit hyperactivity disorder drugs doubled between 2000 and 2004 while their spending on the drugs quadrupled. "I think this shows a clear recognition and new thinking that treatment for ADHD does not go away for many children after adolescence," Dr. Robert S. Epstein, the company's chief medical officer, told The New York Times. A recent Harvard study concluded that some 4 percent of American adults suffered from symptoms of ADHD.

- read this article from The New York Times for more

Suggested Articles

Passage Bio filed to raise $125 million in its IPO. Now, it has outraised that goal by $91 million with a $216 million Wall Street debut.

The ruling reflects the judge’s belief that the FDA’s interpretation of the law on clinical trial reporting “is unlawful and must be set aside.”

Trutino will apply a platform designed to yield safer, more effective cytokines to the discovery of three oncology drugs for Boehringer.